Skip to main content

MoneyWorks4Me

ANG Lifesciences India informs about disclosure

26 Feb 2022 Evaluate

ANG Lifesciences India has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 for Rajesh Gupta.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..